#-supreme-cellcarta-differentiators-15-144{items-data:[{"text":"Multiplexed by Design "},{"text":"Custom Panel Flexibility "},{"text":"Reliable Results "},{"text":"GLP/GCLP Validated"},{"text":"Low Sample Requirements "}]}#-supreme-cellcarta-faq-13-144{items-data:[{"faq_question":"What is Meso Scale Discovery® (MSD)? ","faq_answer":"Meso Scale Discovery® (MSD) is an electrochemiluminescent (ECL)-based detection platform used for multiplexed,high-sensitivity,quantitative immunoassays. MSD® boasts several advantages over similar platforms like ELISA,including lower limits of detection and broader dynamic ranges. CellCarta offers the MSD® platform for cytokine and chemokine screening,providing quantitative data from serum or plasma samples as small as 25 µL. "},{"faq_question":"How many analytes can MSD® measure at once? ","faq_answer":"<p>In a 96-well or 384-well plate format,CellCarta's MSD&reg;assays can measure up to 10 analytes per well simultaneously. MSD&reg;&nbsp;also offers single plex and up to 40 plex formats that can be customized for your specific cytokines and chemokines of interest. All formats enable high-throughput,cost-effective data generation without a proportional increase in sample volume requirements.</p>"},{"faq_question":"Can MSD® be used in clinical trials? ","faq_answer":"<p>Yes. CellCarta has quantified and characterized assays for use in clinical trials. For example,our proinflammatory MSD&reg;panel has been validated for use as secondary endpoints and is CLIA-certified,enabling deployment in regulated clinical laboratory settings. Multi-analyte MSD assays can also be performed in GLP/GCLP-validated environments to support submission-ready regulatory data packages for clinical development programs.</p>"},{"faq_question":"What sample types and volumes does MSD® require? ","faq_answer":"<p>CellCarta's Meso Scale Discovery assays are typically designed to run on serum or plasma samples. Multiplexed measurements of up to 10 analytes require as little as 25 &micro;L of sample per well,allowing for the preservation of limited and/or precious clinical samples while generating comprehensive immune profile data from a single measurement.</p>"}]}#-supreme-cellcarta-featured-resources-16-144{cards-data:[{"image_url":"\/wp-content\/uploads\/2026\/05\/webinar.jpg","card_type":"Webinar","date":"Feb 12","reading_time":"Reading Time - 5 minutes","title":"Resources Title Goes Here","description":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit. Aenean commodo ligula eget dolor.","url":"#"},{"image_url":"\/wp-content\/uploads\/2026\/05\/webinar-2.jpg","card_type":"Webinar","date":"Feb 12","reading_time":"Reading Time - 5 minutes","title":"Resources Title Goes Here","description":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit. Aenean commodo ligula eget dolor.","url":"#"},{"image_url":"\/wp-content\/uploads\/2026\/05\/webinar-3.jpg","card_type":"Webinar","date":"Feb 12","reading_time":"Reading Time - 5 minutes","title":"Resources Title Goes Here","description":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit. Aenean commodo ligula eget dolor.","url":"#"}]}#-supreme-cellcarta-service-blocks-45-176{blocks-data:[{"image":"https://cellcarta.com/wp-content/uploads/2026/06/ELISA-Services-Hero-446.jpg","image_alt":"","title":"ELISA ","description":"Quantify specific biomarkers with a well-established single-analyte assay at high throughput.","button_text":"Discover","button_url":"/capabilities/immunoassay-services/elisa/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/06/Hybrid-LBALC-MS-Hero-33.jpg","image_alt":"","title":"Hybrid LBA/LC-MS","description":"Combine immunoaffinity enrichment with LC-MS for sensitive quantification of biologics.","button_text":"Discover","button_url":"/capabilities/immunoassay-services/hybrid-lba-lc-ms/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/Olink_PEA_Enhanced.png","image_alt":"","title":"Olink® PEA Technology ","description":"Quantify protein biomarkers using just 1µL of blood with high sensitivity and specificity. ","button_text":"Discover","button_url":"/capabilities/immunoassay-services/olink-pea-technology/","button_target":"_self"}]}#-supreme-cellcarta-tab-content-11-144{tabs-data:[{"tab_title":"Multiplexing ","content_title":"","content_body":"MSD® allows for up to 10 analytes to be investigated per well from a single 96-well plate or 384-well plate and offers up to a 40 plex format that can be customized for your biomarker of interest. This approach ultimately enables high throughput and cost-effective data generation when measuring two or more analytes simultaneously is a necessity. ","tab_image":"https://cellcarta.com/wp-content/uploads/2026/07/PC-MSD.jpg","image_alt":""},{"tab_title":"High Performance ","content_title":"","content_body":"<p>MSD delivers low limits of detection and broad dynamic ranges,providing reliable quantitative data across a wide concentration span. These features can be critical for measuring immune responses in a clinical setting.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta_-29-2-1-scaled.jpg","image_alt":""},{"tab_title":"Low Sample Input ","content_title":"","content_body":"MSD® accommodates multiplexed assays with starting sample volumes as low as 25 µL. This allows researchers to conserve precious patient samples while generating comprehensive cytokine and chemokine profiles from a single measurement.","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/CellCarta-237.jpg","image_alt":""},{"tab_title":"Assay Flexibility ","content_title":"","content_body":"<p>CellCarta supports and validates standard multiplex MSD&reg;panels investigating cytokines,chemokines,and inflammation markers.</p>\n<p>Alternatively,your team can work with CellCarta to design custom MSD&reg;panels tailored to your specific analyte targets. We can design panels that investigate up to 10 analytes simultaneously,and perform validation for your specific clinical applications.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/CellCarta-128.jpg","image_alt":""},{"tab_title":"Reliable ","content_title":"","content_body":"<p>CellCarta has extensive experience designing and optimizing MSD&reg;assays for use in clinical trials. Notably,our panels are CLIA-certified and have been validated for exploratory and secondary endpoints,ensuring your workflow returns reliable,reproducible results.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta_-1-scaled.jpg","image_alt":""}]}